The MYC inhibitors 361 and 975 (MYCi361 and MYCi975) exhibit substantial anti-tumor effectiveness by disrupting the MYC-MAX and promoting MYC phosphorylation on threonine-58.122. This evidence concerns the gene MYC and neoplasm.